摘要
目的评价脂微球前列腺素E1治疗急性脑梗死的疗效。方法将87例急性脑梗死患者分为对照组(n=43)和观察组(n=44),2组患者在常规治疗的基础上,对照组给予复方丹参16 mL+低分子右旋糖酐500 mL静脉滴注,1次/d;观察组给予脂微球前列腺素E110μg+生理盐水100 mL静脉滴注,1次/d,2组疗程均为14 d。对2组治疗效果和美国国立卫生院卒中量表(NIHSS)评分进行比较。结果观察组总有效率77.3%,高于对照组的55.8%,差异有统计学意义(P<0.05);2组患者治疗前NIHSS量表评分无统计学差异,治疗后观察组为(13.1±2.0)分,对照组为(14.3±2.3)分,2组比较有统计学差异(P<0.05)。结论脂微球前列腺素E1治疗急性脑梗死效果满意,值得临床推广。
Objective To explore the therapeutic effect of lipopectic prostaglandin E 1 in the treatment of patients with acute cerebral infarction. Methods 87 cases died of cerebral infarction patients were divided into control group （n=43） and observation group （n=44）. Patients in the 2 groups on the basis of conventional therapy, the control group were treated with Compound Danshen 16 mL＋ low molecular dextran 500 mL intravenous drip,1 times /d,the observation group were given lipopectic prostaglandin E110 μ g＋ 100 mL saline infusion,1 times /d,treatment for 14 days.To evaluate the therapeutic effect and NIHSS scale. Results The observation group the total effective rate was 77.3%, higher than 55.8% in the control group,P＆lt;0.05, the difference was statistically significant;the 2 groups of patients before treatment NIHSS score no significant difference after treatment,observation group （13.1＆#177;2.0）,control group（14.3＆#177;2.3）, by comparison（P＆lt;0.05）,there was statistical differences. Conclusion lipopectic prostaglandin E1 in treating acute cerebral infarction with satisfactory effect,is worth the clinical promotion.
出处
《基层医学论坛》
2014年第7期822-823,共2页
The Medical Forum
